Back to Search
Start Over
Right superior frontal gyrus: A potential neuroimaging biomarker for predicting short-term efficacy in schizophrenia.
- Source :
-
NeuroImage. Clinical [Neuroimage Clin] 2024; Vol. 42, pp. 103603. Date of Electronic Publication: 2024 Apr 03. - Publication Year :
- 2024
-
Abstract
- Antipsychotic drug treatment for schizophrenia (SZ) can alter brain structure and function, but it is unclear if specific regional changes are associated with treatment outcome. Therefore, we examined the effects of antipsychotic drug treatment on regional grey matter (GM) density, white matter (WM) density, and functional connectivity (FC) as well as associations between regional changes and treatment efficacy. SZ patients (n = 163) and health controls (HCs) (n = 131) were examined by structural magnetic resonance imaging (sMRI) at baseline, and a subset of SZ patients (n = 77) were re-examined after 8 weeks of second-generation antipsychotic treatment to assess changes in regional GM and WM density. In addition, 88 SZ patients and 81 HCs were examined by resting-state functional MRI (rs-fMRI) at baseline and the patients were re-examined post-treatment to examine FC changes. The Positive and Negative Syndrome Scale (PANSS) and MATRICS Consensus Cognitive Battery (MCCB) were applied to measure psychiatric symptoms and cognitive impairments in SZ. SZ patients were then stratified into response and non-response groups according to PANSS score change (≥50 % decrease or <50 % decrease, respectively). The GM density of the right cingulate gyrus, WM density of the right superior frontal gyrus (SFG) plus 5 other WM tracts were reduced in the response group compared to the non-response group. The FC values between the right anterior cingulate and paracingulate gyrus and left thalamus were reduced in the entire SZ group (n = 88) after treatment, while FC between the right inferior temporal gyrus (ITG) and right medial superior frontal gyrus (SFGmed) was increased in the response group. There were no significant changes in regional FC among the non-response group after treatment and no correlations with symptom or cognition test scores. These findings suggest that the right SFG is a critical target of antipsychotic drugs and that WM density and FC alterations within this region could be used as potential indicators in predicting the treatment outcome of antipsychotics of SZ.<br /> (Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.)
- Subjects :
- Humans
Male
Female
Adult
Gray Matter diagnostic imaging
Gray Matter pathology
Gray Matter drug effects
Prefrontal Cortex diagnostic imaging
Prefrontal Cortex pathology
Middle Aged
Treatment Outcome
White Matter diagnostic imaging
White Matter pathology
Young Adult
Neuroimaging methods
Biomarkers
Schizophrenia diagnostic imaging
Schizophrenia drug therapy
Schizophrenia pathology
Schizophrenia physiopathology
Magnetic Resonance Imaging methods
Antipsychotic Agents pharmacology
Antipsychotic Agents therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 2213-1582
- Volume :
- 42
- Database :
- MEDLINE
- Journal :
- NeuroImage. Clinical
- Publication Type :
- Academic Journal
- Accession number :
- 38588618
- Full Text :
- https://doi.org/10.1016/j.nicl.2024.103603